UNSPSC 51284901: Sulfamethizole/trimethoprim

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AM650. This VA Drug Class (AM650) classifies this compound as belonging to the group SULFONAMIDE/RELATED ANTIMICROBIALS.

UNSPSC 51284901 Sulfamethizole/trimethoprim is a Commodity code, but the recent state and local opportunities posted under it show minimal alignment with this specific antibiotic. The opportunities tagged to this code instead reflect a broader pattern of pharmaceutical and medical supply procurement by state health agencies, counties, cities, and cooperative purchasing alliances sourcing naloxone, first-aid supplies, generic multi-source pharmaceuticals, and direct-to-manufacturer prescription programs. State and local governments use this code (or codes near it in the pharmaceutical taxonomy) to procure medications, emergency medical supplies, and pharmacy benefit management services across diverse jurisdictions and issuing bodies, from single counties and cities to multi-state cooperative purchasing vehicles. The mix of issuing bodies includes county health departments (Seminole County, Florida), municipal fire and rescue divisions (City of Tampa), state health and human services agencies (Texas HHS Commission), and cooperative purchasing alliances serving multiple states (Minnesota Multistate Cooperative Purchasing Alliance).

Recent activity spans Florida, Texas, Minnesota, and Oregon through coordinated multi-state procurement. Representative recent opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (IFB 60459723LAS, due July 26, 2023); the City of Tampa's sealed-bid solicitation for 169 line items of medical and first-aid supplies for its Fire Department Rescue Division with an estimated contract value of $700,000.00 (26P00145, due March 13, 2026, sheltered for certified Small Local Business Enterprises with a 5 percent bid discount); Minnesota's MMCAP RFP for generic multi-source pharmaceuticals and over-the-counter products to be distributed across state and local facilities in participating jurisdictions including Oregon (S1070000015802, due March 26, 2026); and Texas HHS Commission's RFI on a Direct-to-Manufacturer Prescriptions program (HHS0017013, posted April 3, 2026). The code shows sparse recent activity directly tied to sulfamethizole/trimethoprim as a single-agent drug; opportunities cluster instead around broad emergency medical supplies, generic pharmaceutical sourcing, and pharmacy program redesign.